Search clinical trials for: castrate resistant prostate cancer
Total 90561 results
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
BayerCompletedProstate CancerUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam UniversityUnknownProstate Cancer | Prostatic Neoplasms, Castration-ResistantUnited Kingdom
-
University of Colorado, DenverJanssen Services, LLCTerminatedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Cancer | Metastatic Castrate Resistant Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsTerminatedProstate Cancer | Castrate Resistant Prostate Cancer | Chemotherapy Naive Prostate CancerUnited States
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Mary-Ellen Taplin, MDCompletedProstate CancerUnited States
-
INSYS Therapeutics IncWithdrawnProstate CancerUnited States
-
Asana BioSciencesTerminatedProstate Cancer | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Prostate Neoplasms, Castration-resistantUnited States
-
Carolina Research Professionals, LLCBayerCompleted
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNeuroendocrine Prostate Cancer | Small Cell Prostate Cancer | Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine MarkersUnited States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Edwin Posadas, MDCompletedProstate CancerUnited States
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Queen's Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHormone Refractory Prostate CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisSanofiUnknownMetastatic Castration-resistant Prostate CancerFrance
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
DendreonTerminated
-
SOTIO a.s.CompletedProstate Cancer | Prostate Cancer MetastaticCzechia
-
Andrew J. Armstrong, MDNovartis PharmaceuticalsTerminatedProstate Cancer | Metastatic (Spread to Other Areas of the Body)United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New JerseyTerminated
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
BayerCompletedProstatic NeoplasmsBelgium, Spain, Canada, France, Switzerland, Germany, United Kingdom, Denmark, Russian Federation, Sweden, Israel, Italy, Netherlands, Norway, Czech Republic, Finland, Poland, Ireland, Mexico
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Northwestern UniversityGenzyme, a Sanofi CompanyWithdrawnPROSTATE CANCERUnited States
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
Massachusetts General HospitalCompletedProstate AdenocarcinomaUnited States
-
Achieve Life SciencesTeva Branded Pharmaceutical Products R&D, Inc.CompletedProstate CancerUnited States, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
SanofiCompletedProstate CancerFrance, United Kingdom, United States
-
Millennium Pharmaceuticals, Inc.Completed
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAureon Biosciences, Inc.; NYU MEDICAL CENTERCompleted
-
Hadassah Medical OrganizationUnknown
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of WashingtonCompletedProstate Cancer | Castration-resistant, MetastaticUnited States
-
Bastyr UniversityUniversity of Washington; Fred Hutchinson Cancer CenterWithdrawnProstatic NeoplasmsUnited States
-
Active Biotech ABCompleted
-
M.D. Anderson Cancer CenterCompletedProstate CancerUnited States
-
Active Biotech ABCompletedProstate CancerFrance, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
-
Lawrence FongBristol-Myers Squibb; SanofiWithdrawn
-
Duke UniversityUnited States Department of DefenseWithdrawn
-
University Health Network, TorontoCompletedProstate Cancer (Adenocarcinoma)Canada